Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae.
Filippos VingopoulosDouglas R LazzaroPublished in: International medical case reports journal (2020)
As dupilumab injections begin to claim a rightful place in medicine, the ophthalmic community may start encountering dupilumab-associated ocular surface disease all more often and potentially play an important role in identifying, characterizing and treating the adverse ocular effects from this novel medication.